Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/18006697

Blood 2008 Feb 1 111 3 1654-64

Download in:

View as

Triples

General Info

PMID
18006697